Published in Drug Week, December 10th, 2010
"This peptide was used to target nabpaclitaxel to irradiated tumors, achieving tumor-specificity and enhanced bioavailability of paclitaxel. Optical imaging studies showed that HVGGSSV-guided nab-paclitaxel selectively targeted irradiated tumors and showed 1.48 +/- 1.66...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.